BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Greenberg Traurig Maher Advises on US$330 Million Sale of ApaTech Ltd to Baxter International, Inc. (BAX)


3/18/2010 11:16:09 AM

LONDON, March 18 /PRNewswire/ -- Greenberg Traurig Maher LLP represented the private equity sellers and senior management of ApaTech Limited, a private equity-backed, UK-based orthobiologic products company, in its sale to global health care company Baxter International Inc. The transaction closed on 12 March and, as a result, Baxter acquired all of the outstanding equity of ApaTech for total consideration of up to US$330 million.

In this transaction, Baxter acquired ACTIFUSE, a silicate substituted calcium phosphate synthetic bone graft material currently marketed in the United States, EU and other select markets around the world. Baxter also acquired manufacturing and R&D facilities located in the UK, United States and Germany.

Under the terms of the agreement, Baxter made an upfront cash payment of US$240 million, and may make additional payments of up to US$90 million related to the achievement of sales milestones.

Greenberg Traurig Maher LLP was established in 2009 in the UK by international law firm Greenberg Traurig, LLP. Greenberg Traurig Maher's rapidly expanding office provides shareholder-led advice to domestic and international clients on a range of matters across the legal spectrum. Lawyers at Greenberg Traurig Maher advise UK and multinational clients operating in many different sectors, including chemicals, pharmaceuticals, life sciences, energy, real estate, financial services, information services, automotive, entertainment, retail and communications. For additional information, please visit www.gtmlaw.com.

Greenberg Traurig, LLP is an international, full-service law firm with approximately 1775 attorneys serving clients from more than 30 offices in the United States, Europe and Asia. In the U.S., the firm has more offices than any other among the Top 20 on The National Law Journal's 2009 NLJ 250. In the U.K., the firm operates as Greenberg Traurig Maher LLP. Additionally, Greenberg Traurig has strategic alliances with the following independent law firms: Studio Santa Maria in Milan and Rome, TA Lawyers GKJ in Tokyo, and Weber Law Office in Zurich. The firm was Chambers and Partners' USA Law Firm of the Year in 2007 and among the Top 3 in the International Law Firm of the Year.

CONTACT: Wendy Valecha, +1-212-801-6708, valechaw@gtlaw.com, or Lourdes
Brezo-Martinez, +1-212-801-2131, martinezl@gtlaw.com, both of Greenberg
Traurig

Web site: http://www.gtmlaw.com/



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES